Scott Reents
Directeur Financier/CFO chez TOBIRA THERAPEUTICS INC
Fortune : 3 M $ au 30/04/2024
Profil
Mr. Scott T.
Reents is a Chief Financial Officer & Executive Vice President at AbbVie, Inc., a Chief Financial Officer at Tobira Therapeutics, Inc., a President & Director at Allergan, Inc. and a President & Director at Oculeve, Inc. He is on the Board of Directors at Allergan, Inc. and Oculeve, Inc. Mr. Reents was previously employed as a Vice President-Tax by Abbott Laboratories.
He received his undergraduate degree from the University of Nebraska, a graduate degree from the University of Washington and an MBA from the University of Washington.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ABBVIE, INC.
0,00% | 28/02/2024 | 15 431 ( 0,00% ) | 3 M $ | 30/04/2024 |
Postes actifs de Scott Reents
| Sociétés | Poste | Début |
|---|---|---|
| TOBIRA THERAPEUTICS INC | Directeur Financier/CFO | - |
| ABBVIE INC. | Directeur Financier/CFO | 23/06/2022 |
| ALLERGAN, INC. | President | - |
Oculeve, Inc.
 Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | President | - |
Anciens postes connus de Scott Reents
| Sociétés | Poste | Fin |
|---|---|---|
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | - |
Formation de Scott Reents
| University of Nebraska | Undergraduate Degree |
| University of Washington | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ABBVIE INC. | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| Entreprise privées | 3 |
|---|---|
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on September 11, 2006 and is headquartered in Madison, NJ. | Health Technology |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | Health Technology |